FY2025 · period end Dec '25 · from the 10-K filed Feb 4, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.63B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001932393-26-000034 | May 7, 2026 | May 11, 2026 | May 11, 2026 20:51 UTC | EDGAR |
| 8-K | 0001932393-26-000030 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 10:25 UTC | EDGAR |
| 10-Q | 0001932393-26-000031 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 10:26 UTC | EDGAR |
| 8-K | 0001932393-26-000013 | Mar 13, 2026 | Mar 17, 2026 | Mar 17, 2026 13:14 UTC | EDGAR |
| 8-K | 0001932393-26-000010 | Feb 26, 2026 | Feb 27, 2026 | Feb 27, 2026 21:15 UTC | EDGAR |
| 8-K | 0001932393-26-000006 | Feb 4, 2026 | Feb 4, 2026 | Feb 4, 2026 11:25 UTC | EDGAR |
| 10-K | 0001932393-26-000007 | Dec 31, 2025 | Feb 4, 2026 | Feb 4, 2026 11:28 UTC | EDGAR |
| 8-K | 0001193125-25-319383 | Dec 12, 2025 | Dec 15, 2025 | Dec 15, 2025 22:02 UTC | EDGAR |
Direct links to SEC EDGAR. GEHC has additional filings available on the SEC site.
6 numbers GE HealthCare Technologies Inc. later changed — same XBRL tag, both filings linked.
Increase (Decrease) in Accounts Payable·FY 2023
Major restatementwas-$13M
Revised down in a 10-K.
Increase (Decrease) in Accounts Payable·Q2 2024
Major restatementwas-$41M
Revised down in a 10-Q.
Increase (Decrease) in Accounts Payable·Q1 2024
Major restatementwas$81M
Revised down in a 10-Q.
Increase (Decrease) in Accounts Payable·FY 2024
Major restatementwas$126M
Revised down in a 10-K.
Restructuring Charges·FY 2023
Major restatementwas$54M
Revised down in a 10-K.
Deferred Tax Assets, Net of Valuation Allowance·As of Dec 31, 2023
Notable restatementwas$4.5B
Revised up in a 10-K.
GEHC is not the only one.
See every restatement we've found across the market — or get an alert the next time GEHC revises a number.
Restatements are detected by comparing every vintage of a fact across all of GE HealthCare Technologies Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows GEHC's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling GE HealthCare Technologies Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on GEHC yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on GEHC and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $19.55B |
| $18.34B |
| $17.59B |
| Gross Profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B |
|---|
| Operating Income | $2.76B | $2.63B | $2.44B | $2.52B | $2.79B |
|---|
| Net Income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
|---|
| EPS (Diluted) | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $36.91B | $33.09B | $32.45B | $27.54B | — |
| Total Liabilities | $26.31B | $24.44B | $25.14B | $17.95B | — |
| Stockholders' Equity | $10.39B | $8.46B | $7.14B | $9.36B | $16.68B |
| Cash & Equivalents | $4.49B | $2.89B | $2.51B | $1.45B | $0.56B |
| Total Debt | $10.02B | $9.04B | $9.45B | $8.30B | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | — |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 15.9% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 12.8% |
| Return on Equity | 22.1% | 25.5% | 19.0% | 14.7% | 13.5% |
| Return on Assets | 6.0% | 6.1% | 5.2% | 7.0% | — |
| Debt / Equity | 0.96× | 1.07× | 1.32× | 0.89× | — |
